Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03650920 · ClinicalTrials.gov registry record · NA
Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT03650920 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 89 participants.
The verdict
NCT03650920, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.
Interventions
- PROCEDURE Liver Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-09-02 |
| Est. Completion | 2021-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03650920
The ClinicalTrials.gov registry entry for NCT03650920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liver Transplantation is the first listed.
NCT03650920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03650920 about?
NCT03650920 is a clinical study titled "Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients". To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.
What is the current status of trial NCT03650920?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2018-09-02. Estimated completion is 2021-02-19.
What interventions are being tested in trial NCT03650920?
The interventions under investigation include: Liver Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT03650920?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.